ArticleGlia2026
Neuronal Overexpression of Glycogen Synthase Kinase-3β Accelerates Age-Related Glial, Vascular, and Inflammatory Remodeling of the Murine Dentate Gyrus.
Article in Glia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Adult hippocampal neurogenesis (AHN)-the lifelong generation of new neurons in the dentate gyrus (DG)-depends on the integrity of the subgranular zone (SGZ) neurogenic niche, which comprises astrocytes, microglia, oligodendroglial cells, and a dense vascular network. Although AHN declines during aging and is impaired in Alzheimer's disease (AD), the cell-type-specific alterations within the DG underlying this decline remain poorly characterized. Given the critical role of glycogen synthase kinase-3β (GSK-3β) in AD pathogenesis and AHN regulation, we studied how the overexpression of this kinase in dentate granule cells (DGCs) remodels the cellular and vascular composition of the DG throughout life. Using a layer-resolved approach (SGZ vs. granule cell layer (GCL)) and mice of distinct ages (4-30 months), we quantified glial densities, cellular contacts, vascular architecture, and cytokine profiles in wild-type (WT) and GSK-3β-overexpressing (GSK-3β-OE) mice. In the former, aging was associated with a layer-specific reorganization, characterized by progressive astrocyte loss in the SGZ, midlife increases in GCL microglia, a reduction in oligodendroglial progenitors, and enhanced SGZ vascularization. GSK-3β overexpression accelerated age-related changes, triggering premature SGZ astrocyte depletion by 4 months, broader disruption featuring reduced SGZ microglial and mature oligodendrocyte densities accompanied by increased microglial morphological complexity, vascular restructuring, and a shift toward a pro-inflammatory environment. Therefore, neuronal GSK-3β overexpression promoted a non-cell-autonomous reorganization of the DG, consistent with premature remodeling of the neurogenic niche. These results provide mechanistic insights into AHN failure in AD and point to the modulation of GSK-3β activity as a strategy to preserve DG integrity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.